Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial

Thumbnail Image
eschf_11_6_4201.pdf (360.17 KB)
Identifiers
URI: https://hdl.handle.net/10641/7730
ISSN: 2055-5822
DOI: 10.1002/ehf2.14955

Publication date

2024-12

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Keywords

dilated cardiomyopathy, genetic diseases, heart failure, laminopathies, phase 3 clinical trial, Cardiology and Cardiovascular Medicine, Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, Yes, yes

Citation

Garcia-Pavia, P, Lakdawala, N K, Sinagra, G, Ripoll-Vera, T, Afshar, K, Priori, S G, Ware, J S, Owens, A, Li, H, Angeli, F S, Elliott, P, MacRae, C A & Judge, D P 2024, 'Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial', ESC Heart Failure, vol. 11, no. 6, pp. 4201-4208. https://doi.org/10.1002/ehf2.14955

Collections

FACULTAD DE MEDICINA